Whole Exome Sequencing Market Report 2025 – Insights for Decision Makers and Market Strategists

 Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

 
 What is the forecasted revenue size of the whole exome sequencing industry by 2029?
 The whole exome sequencing market size has grown rapidly in recent years. It will grow from$2.82 billion in 2024 to $3.37 billion in 2025 at a compound annual growth rate (CAGR) of 19.4%. The growth in the historic period can be attributed to genomic research advancements, precision medicine trends, rare disease diagnosis, pharmaceutical and biotech applications, declining sequencing costs
 
 The whole exome sequencing market size is expected to see exponential growth in the next few years. It will grow to “$7.29 billion in 2029 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to expanding applications in oncology, integration in clinical diagnostics, rise in genetic testing demand, population genomics initiatives, emergence of gene therapies. Major trends in the forecast period include enhanced clinical utility and adoption, decreasing costs of sequencing, focus on data security and privacy, integration with electronic health records, advances in single-cell sequencing.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp
 
 Which industry-specific innovations are acting as key drivers for the whole exome sequencing market?
 Increasing HIV (human immunodeficiency virus) prevalence is expected to propel the growth of the whole exome sequencing market going forward. HIV refers to a virus that targets the immune system of the body. Whole exome sequencing is used to provide genomic structures of viruses that are useful for personalized treatment and vaccine designs for HIV. For instance, in August 2024, according to the Minority HIV/AIDS Fund (MHAF), an US-based government agency, an estimated in 2023, approximately 39.9 million individuals worldwide were living with HIV, consisting of 38.6 million adults and 1.4 million children, compared to previous years. Therefore, the increasing HIV prevalence is driving the growth of the whole exome sequencing market.
 
 Which segment currently leads the whole exome sequencing market in terms of revenue share?
 The whole exome sequencing market covered in this report is segmented –
 
 1) By Product: Systems, Kits, Services
 2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies
 3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research
 4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users
 
 Subsegments:
 1) By Systems: Sequencing Systems, Data Analysis Systems
 2) By Kits: Library Preparation Kits, Exome Enrichment Kits, Sequencing Kits
 3) By Services: Data Analysis Services, Consulting Services, Custom Sequencing Services
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report
 
 What are the top market trends driving innovation in the whole exome sequencing industry?
 Innovative diagnostic techniques are a key trend gaining popularity in the whole exome sequencing market. Companies operating in the whole exome sequencing market are working on new product innovations to sustain their position in the market. For instance, in February 2023, Illumina Inc., a US-based biotechnology company launched NovaSeqX Plus, the most powerful sequencing technology, delivering an unprecedented combination of high throughput and accuracy and featuring streamlined informatics, sustainability advancements, and economical sequencing. The innovations built into the NovaSeq X Plus systems have the power to generate tens of thousands of whole genomes per year, maximize productivity, and minimize turnaround time.
 
 Who are the top competitors in the global whole exome sequencing market?
 Major companies operating in the whole exome sequencing market include Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics, Psomagen Inc., Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche Ltd., QIAGEN Inc., Macrogen Inc., Ambry Genetics, Bio-Rad Laboratories Inc., Bioneer Corporation, Foundation Medicine Inc., KONICA MINOLTA INC., Otogenetics Corporation, Geneyx Genomex Ltd., ArcherDX Inc., Blueprint Genetics Oy, Bionano Genomics Inc., Centogene AG, Fulgent Genetics Inc., Natera Inc., GeneDx Inc., GENEWIZ Inc., Novogene Corporation, PerkinElmer Inc., Personalis Inc.
 
 What regional dynamics are shaping the future of the global whole exome sequencing market?
 North America was the largest region in the whole exome sequencing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Whole Exome Sequencing Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10669
 
 Need Customized Data On Whole Exome Sequencing Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=10669&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company